Avingtrans’ Energy Steel awarded a $4.1M contract from Nuclear Waste Partnership

Avingtrans plc

Avingtrans PLC (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced Energy Steel has been awarded a $4.1M contract from Nuclear Waste Partnership LLC.

Drew Baker, President of Energy Steel, commented:

“We’re delighted that Energy Steel continues to gather momentum and this contract supports continuing growth. Energy Steel has been serving the nuclear industry over the last 40 years, and we are honored to support one of the most ambitious energy projects in the world today.”

Energy Steel, part of the Engineered Pumps and Motors Division of Avingtrans plc and leader in high quality components, fabrications, and materials for the nuclear energy sector, has been awarded a $4.1M contract from Nuclear Waste Partnership LLC. The contract, which is expected to be completed by June 2023, includes the supply of materials and subassemblies required for the waste isolation pilot plant (WIPP), the nation’s only deep geological long-lived radioactive waste repository. The materials and subassemblies will be used in the construction of the TRUPACT-II and HalfPACT Type B packages developed by the U.S. Department of Energy. Both packages are utilized as a safe means for the transportation of transuranic materials and designed to reduce the number of radioactive shipments.

Share on:

Latest Company News

Avingtrans appoints Stuart Gall as CEO of Medical and Industrial Imaging division

Avingtrans plc has announced that Stuart Gall officially assumed the role of Chief Executive Officer of its medical and industrial imaging division on 1 January 2026.

Avingtrans subsidiary Adaptix gains FDA clearance for Ortho350

Avingtrans reported that its subsidiary Adaptix has received FDA 510(k) clearance for the Ortho350, a compact 3D orthopaedic imaging system designed for point of care use.

Avingtrans CEO on record revenue and strong order book momentum for FY25 (LON:AVG)

Avingtrans has delivered record revenue of £156.4 million for FY25, with Chief Executive Officer Steve McQuillan highlighting robust order book growth, major contract wins, and increasing demand across energy, defence, infrastructure and medical divisions.

Avingtrans appoints Stuart Gall as CEO of medical imaging division

Avingtrans Plc has announced the appointment of Stuart Gall as Divisional Chief Executive Officer of its medical imaging businesses, including Adaptix and Magnetica, effective on or before 10 March 2026.

Avingtrans Plc Record Results, New Nuclear Wins and the Power of AI-Driven Demand (Video)

Avingtrans CEO Steve McQuillan shares how AI, energy and infrastructure megatrends are driving record results — and why strategic deals could be back on the table in FY26.

Avingtrans reports record revenue and earnings growth in FY25

Avingtrans posted preliminary results for the year ended 31 May 2025, with revenue up 14.5% to a record £156.4m and adjusted EBITDA rising to £16.7m. Adjusted profit before tax increased 18% to £8.6m, while diluted EPS grew 28% to 23.7p.

    Search

    Search